Hence, a long-term increase in peripheral blood CCR6- and CXCR5-expressing CD8+ T cells in COVID-19 convalescents revealed in our study might be considered one of the signals associated with long-COVID alterations in cytotoxic T cell subset composition. The gene discussed is CCR6; the disease is COVID-19.